Edward R. Truitt, III, J.D. – Co-Founder and Chief Executive Officer – is an entrepreneur and corporate attorney. He is a co-founder of Biological Dynamics, Inc., a molecular diagnostics company focusing on the early detection of cancer. Mr. Truitt received his JD from the University of San Diego. Prior to becoming an entrepreneur, Mr. Truitt had an active practice in corporate law, focusing on business formation and patent litigation.
Harry Barnett, J.D. – Co-Founder and Executive Chairman – is a biotechnology/pharmaceutical entrepreneur with nearly 2 decades of experience in founding and operating successful life science technology development and service companies. In 1997, he co-founded and co-managed Biomodels, a preclinical drug development contract research company based in Watertown, Massachusetts. In 1999, Mr. Barnett co-founded Clinical Assistance Programs, an oncology-focused, clinical research and consulting company based in Framingham, Massachusetts where he currently serves as Managing Partner. Previously, Mr. Barnett was the founder and CEO of Receptor, Inc. where his leadership resulted in the commercialization of technology supporting the launch of Johnson & Johnson Merck’s OTC heartburn combination product, Pepcid Complete. Mr. Barnett received his undergraduate degree from Tufts University and his J.D. from Boston University School of Law.
Benjamin Sullivan, Ph.D. – Co-Founder, Board Member – is the CSO of TearLab Corp., a publicly traded medical device company focusing on point of care diagnostics for Dry Eye Disease. Prior to obtaining his Ph.D. in Bioengineering at the University of California, San Diego, Benjamin spent six years researching effects of Dry Eye Disease on molecular profiles of the tear film while at the Schepens Eye Research Institute, an affiliate of Harvard Medical School.
Edmund R. Pitcher, J.D. – Co-Founder & Board Member – Mr. Pitcher is of counsel to Goodwin Procter and a member of its Technology & Life Sciences Group and its Technology Transactions and Patent Prosecution & Counseling Practices. He has more than 35 years’ experience in all aspects of intellectual property law as counsel to companies exploiting biological, pharmaceutical, chemical and medical technologies, and to their private and public investors. Mr. Pitcher has advised operating companies, venture capital limited partnerships and securities analysts on intellectual property matters, risks and strategies. He has also been involved with domestic and foreign patent portfolio development, technology transfer, patent enforcement litigation, patent defense litigation, IP diligence, freedom to operate risk assessments, patentability assessments and IP valuation efforts. For his practical, business perspective and his deep legal, business and scientific experience, he has been recognized by Chambers USA and the IAM Patent 1000, which noted that he is “among the most commercially astute patent law experts.”